erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Tuberculosis D014376 20 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Ruess M et al. Antimicrobial susceptibility patterns of Streptococcus agalactiae in a German university hospital. 2000 Scand. J. Infect. Dis. pmid:11200371
Shulman ST and Ayoub EM The control of rheumatic fever. 1975 Clin Pediatr (Phila) pmid:1120375
Mazur E et al. Susceptibility to selected antibiotics of Streptococcus pneumoniae and Streptococcus pyogenes strains isolated from patients with respiratory tract infections. 1999 Ann Univ Mariae Curie Sklodowska Med pmid:11205800
Mikucka A et al. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998. 2000 Mar-Apr Med. Sci. Monit. pmid:11208326
Izard J et al. Cytoplasmic filament-deficient mutant of Treponema denticola has pleiotropic defects. 2001 J. Bacteriol. pmid:11208807
Bombassaro AM et al. Clostridium difficile colitis following antibiotic prophylaxis for dental procedures. 2001 J Can Dent Assoc pmid:11209501
Arciola CR et al. Adhesion to a polymeric biomaterial affects the antibiotic resistance of Staphylococcus epidermidis. 2001 New Microbiol. pmid:11209844
Sáez-Llorens X et al. [Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia]. 1998 Rev Med Panama pmid:11214557
Gilliet F [Treatment of early syphilis under conditions of penicillin intolerance]. 1975 Schweiz Med Wochenschr pmid:1121651
Warkany J A warfarin embryopathy? 1975 Am. J. Dis. Child. pmid:1121959
de Dios García-Díaz J et al. [Phlebitis due to intravenous administration of macrolide antibiotics. A comparative study of erythromycin versus clarithromycin]. 2001 Med Clin (Barc) pmid:11222159
van der Toorn F and Lumeij JT [Streptococcus gallolyticus infections in racing pigeons, a literature review]. 2001 Tijdschr Diergeneeskd pmid:11227399
Alimchandani A and Pai-dhungat JV A study of gastric emptying in chronic renal failure. 1997 J Assoc Physicians India pmid:11229179
Pfeifer BA et al. Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. 2001 Science pmid:11230695
Labro MT and Abdelghaffar H Immunomodulation by macrolide antibiotics. 2001 J Chemother pmid:11233797
Hashimoto N et al. Effect of erythromycin on matrix metalloproteinase-9 and cell migration. 2001 J. Lab. Clin. Med. pmid:11241027
Hofstetter A [Treatment of chlamydial urethroadnexitis with erythromycin (author's transl)]. 1979 MMW Munch Med Wochenschr pmid:112423
Nasser AA and Bizri AR Chronic scalp wound infection due to Rhodococcus equi in an immunocompetent patient. 2001 J. Infect. pmid:11243757
Uh Y et al. Emerging erythromycin resistance among group B streptococci in Korea. 2001 Eur. J. Clin. Microbiol. Infect. Dis. pmid:11245325
Stamos G et al. Emergence of group A beta-hemolytic streptococci resistant to erythromycin in Athens, Greece. 2001 Eur. J. Clin. Microbiol. Infect. Dis. pmid:11245331
Hladka OA and Motyka OI [Formation of erythromycin resistance in Corynebacterium diphtheriae induced by long-term effect of the antibiotic]. 2000 Sep-Oct Mikrobiol. Z. pmid:11247343
Wagner CM The care and management of pertussis in pediatric patients. 2001 Mar-Apr Air Med. J. pmid:11250611
Ross JI et al. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. 2001 Br. J. Dermatol. pmid:11251569
Bergogne-Bérézin E and Bryskier A The suppository form of antibiotic administration: pharmacokinetics and clinical application. 1999 J. Antimicrob. Chemother. pmid:11252322
Fernández-Roblas R et al. The bactericidal activities of HMR 3004, HMR 3647 and erythromycin against gram-positive bacilli and development of resistance. 1999 J. Antimicrob. Chemother. pmid:11252337
Nait-Kaci S et al. [Sensitivity to beta lactams and macrolides of Streptococcus pyogenes isolated at the services from 1994 to 1998]. 1998 Arch Inst Pasteur Alger pmid:11256303
Perreten V et al. Mdt(A), a new efflux protein conferring multiple antibiotic resistance in Lactococcus lactis and Escherichia coli. 2001 Antimicrob. Agents Chemother. pmid:11257023
Koeck JL et al. [First confirmed case of laryngeal diphtheria in Djibouti]. 2000 Med Trop (Mars) pmid:11258062
Yamano K et al. Prediction of midazolam-CYP3A inhibitors interaction in the human liver from in vivo/in vitro absorption, distribution, and metabolism data. 2001 Drug Metab. Dispos. pmid:11259329
Oliva Rodríguez-Pastor S et al. [Erythromycin and hypertrophic stenosis of the pylorus]. 2001 An. Esp. Pediatr. pmid:11262265
Lunzer MR et al. Jaundice due to erythromycin estolate. 1975 Gastroenterology pmid:1126604
Sanz E et al. Perception of teratogenic risk of common medicines. 2001 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:11267734
Schwartz JB Race but not age affects erythromycin breath test results in older hypertensive men. 2001 J Clin Pharmacol pmid:11269573
Cervin A The anti-inflammatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis. 2001 Acta Otolaryngol. pmid:11270500
Champney WS and Tober CL Structure-activity relationships for six ketolide antibiotics. 2001 Curr. Microbiol. pmid:11270656
Ye H et al. Antimycoplasmal activities of (S)-(-)-9-fluoro-2,3-dihydro-3-methyl-10 -[4-(2-pyridyl)-1-piperazinyl]-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine -6-carboxylic acid (YH-6) in comparison with other antibiotics in vitro. 1999 Zhongguo Yao Li Xue Bao pmid:11270970
Avanzini C et al. Streptococcus pyogenes collected in Torino (northwest Italy) between 1983 and 1998: survey of macrolide resistance and trend of genotype by RAPD. 2000 Microb. Drug Resist. pmid:11272257
Steigbigel RT et al. Antibiotic combinations in the treatment of experimental Staphylococcus aureus infection. 1975 J. Infect. Dis. pmid:1127254
Papudesu B et al. Invasive pneumococcal disease. 2001 Med Health R I pmid:11280137
Leyden JJ et al. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product. 2001 Jan-Feb J Cutan Med Surg pmid:11281433
Ioannidou S et al. Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children. 2001 Int. J. Antimicrob. Agents pmid:11282264
Zouain MG and Araj GF Antimicrobial resistance of Enterococci in Lebanon. 2001 Int. J. Antimicrob. Agents pmid:11282266
Vela AI et al. Antimicrobial susceptibility of Listeria monocytogenes isolated from meningoencephalitis in sheep. 2001 Int. J. Antimicrob. Agents pmid:11282267
Montanari MP et al. Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci. 2001 J. Clin. Microbiol. pmid:11283047
Osato MS et al. Comparative efficacy of new investigational agents against Helicobacter pylori. 2001 Aliment. Pharmacol. Ther. pmid:11284777
Kanellopoulou M et al. Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens. 2000 Clin. Microbiol. Infect. pmid:11284924
Bryskier A Ketolides-telithromycin, an example of a new class of antibacterial agents. 2000 Clin. Microbiol. Infect. pmid:11284926
Ge N et al. Interferon-gamma activates outwardly rectifying chloride channels in the human bronchial epithelial cell line BEAS-2B. 2001 J. Med. Invest. pmid:11286023
Ueno N et al. Erythromycin administration before sleep is effective in decreasing fasting hyperglycemia in type 2 diabetic patients. 2001 Diabetes Care pmid:11289494
Queille-Roussel C et al. Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel. 2001 Clin Ther pmid:11293554
Kenyon SL et al. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group. 2001 Lancet pmid:11293640
Kenyon SL et al. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. ORACLE Collaborative Group. 2001 Lancet pmid:11293641
Kanazawa S et al. The effects of grapefruit juice on the pharmacokinetics of erythromycin. 2001 Jan-Feb Eur. J. Clin. Pharmacol. pmid:11294369
Craft JC ABT-773 overview. 2001 Jpn J Antibiot pmid:11296410
Gunics G et al. Enhanced antibacterial effect of erythromycin in the presence of 3,5-dibenzoyl-1,4-dihydropyridines. 2001 Jan-Feb Anticancer Res. pmid:11299745
Tsunoda SM et al. Preliminary evaluation of progestins as inducers of cytochrome P450 3A4 activity in postmenopausal women. 1998 J Clin Pharmacol pmid:11301566
Ip M et al. Macrolide resistance in Streptococcus pneumoniae in Hong Kong. 2001 Antimicrob. Agents Chemother. pmid:11302833
McGee L et al. Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm(B) and mef(A)) in South Africa. 2001 Antimicrob. Agents Chemother. pmid:11302838
Milne RW et al. Hepatic disposition of fexofenadine: influence of the transport inhibitors erythromycin and dibromosulphothalein. 2000 Pharm. Res. pmid:11303961
Trepanier LA and Miller JL NADH-dependent reduction of sulphamethoxazole hydroxylamine in dog and human liver microsomes. 2000 Xenobiotica pmid:11307968
Ripa S et al. SmaI macrorestriction analysis of Italian isolates of erythromycin-resistant Streptococcus pyogenes and correlations with macrolide-resistance phenotypes. 2001 Microb. Drug Resist. pmid:11310805
Fogarty CM et al. Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trials. 2001 Clin Ther pmid:11318077
Ng PC et al. Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants. 2001 Arch. Dis. Child. Fetal Neonatal Ed. pmid:11320044
Rouzica M and Filipová K [On the article of J. Buchanec and V. Kdrajnák: Lesions of the liver during therapy with erythromycin in 3 children]. 1975 Cesk Pediatr pmid:1132045
Lanbeck P and Paulsen O Short-term effects of four antibiotics on DNA synthesis in endothelial cells. 2001 Pharmacol. Toxicol. pmid:11322179
Kim HS et al. Double-edged sword of chemosensitizer: increase of multidrug resistance protein (MRP) in leukemic cells by an MRP inhibitor probenecid. 2001 Biochem. Biophys. Res. Commun. pmid:11322768
Weeda LW Erythromycin and amoxicillin? 2001 J Tenn Dent Assoc pmid:11324196
From the Centers for Disease Control and Prevention. Sudden death in a traveler following halofantrine administration--Togo, 2000. 2001 JAMA pmid:11324646
Rivory LP et al. The erythromycin breath test for the prediction of drug clearance. 2001 Clin Pharmacokinet pmid:11327195
Tsuji SY et al. Selective protein-protein interactions direct channeling of intermediates between polyketide synthase modules. 2001 Biochemistry pmid:11327852
Curry JI et al. Review article: erythromycin as a prokinetic agent in infants and children. 2001 Aliment. Pharmacol. Ther. pmid:11328252
Martin SJ et al. The activity of 14-hydroxy clarithromycin, alone and in combination with clarithromycin, against penicillin- and erythromycin-resistant Streptococcus pneumoniae. 2001 J. Antimicrob. Chemother. pmid:11328768
Zarantonelli L et al. Decreased susceptibility to azithromycin and erythromycin mediated by a novel mtr(R) promoter mutation in Neisseria gonorrhoeae. 2001 J. Antimicrob. Chemother. pmid:11328778
Hattori A et al. [A case of Folliculitis barbae Candidomycetica]. 2001 Nihon Ishinkin Gakkai Zasshi pmid:11331469
Ibarrola M et al. [Disseminated disease by Mycobacterium kansasii resistant to isoniazid and rifampin in patients] with AIDS]. 2001 Enferm. Infecc. Microbiol. Clin. pmid:11333577
Gharpure V et al. Efficacy of erythromycin for postpyloric placement of feeding tubes in critically ill children: a randomized, double-blind, placebo controlled study. 2001 May-Jun JPEN J Parenter Enteral Nutr pmid:11334066
Takiguchi Y et al. Fulminant Mycoplasma pneumoniae pneumonia. 2001 Intern. Med. pmid:11334397
Hondeghem LM et al. Phase 2 prolongation, in the absence of instability and triangulation, antagonizes class III proarrhythmia. 2001 Cardiovasc. Res. pmid:11334838
Gintant GA et al. The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis. 2001 J. Cardiovasc. Pharmacol. pmid:11336111
Rawlings BJ Type I polyketide biosynthesis in bacteria (Part A--erythromycin biosynthesis). 2001 Nat Prod Rep pmid:11336289
Samra Z et al. In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines. 2001 Diagn. Microbiol. Infect. Dis. pmid:11337185
Wang M et al. Prevalence and phenotypes of erythromycin-resistant Streptococcus pneumoniae in Shanghai, China. 2001 Diagn. Microbiol. Infect. Dis. pmid:11337187
Corcoran JW S-adenosylmethionine:erythromycin C O-methyltransferase. 1975 Meth. Enzymol. pmid:1134368
Dobbin CJ et al. The efficacy of an antibiotic protocol for community-acquired pneumonia. 2001 Med. J. Aust. pmid:11346105
Akritopoulou-Zanze I and Sowin TJ Solid-phase synthesis of macrolide analogues. 2001 May-Jun J Comb Chem pmid:11350254
Chitturi S and Farrell GC Drug-induced cholestasis. 2001 Semin. Gastrointest. Dis. pmid:11352118
Bonnefoy A et al. In vivo efficacy of the new ketolide telithromycin (HMR 3647) in murine infection models. 2001 Antimicrob. Agents Chemother. pmid:11353612
Marti García JL et al. [Rheumatic pneumonitis]. 1975 Rev Clin Esp pmid:1135467
Dujovne CA Liver cell culture toxicity and surfactant potency of erythromycin derivatives. 1975 Toxicol. Appl. Pharmacol. pmid:1135866
Rowe CJ et al. Engineering a polyketide with a longer chain by insertion of an extra module into the erythromycin-producing polyketide synthase. 2001 Chem. Biol. pmid:11358694
Ray RS et al. Evaluation of UV-induced superoxide radical generation potential of some common antibiotics. 2001 Drug Chem Toxicol pmid:11360435
Germaniskis L and Singer EJ HIV and peripheral neuropathy. 1995 J Int Assoc Physicians AIDS Care pmid:11362726
Takedomi S et al. In-vivo kinetics of the interaction between midazolam and erythromycin in rats, taking account of metabolic intermediate complex formation. 2001 J. Pharm. Pharmacol. pmid:11370704
Sambol SP et al. Infection of hamsters with epidemiologically important strains of Clostridium difficile. 2001 J. Infect. Dis. pmid:11372028
Fardis M et al. Synthesis of 14,15-dehydroerythromycin A ketolides: effects of the 13-substituent on erythromycin tautomerism. 2001 J. Antibiot. pmid:11372784
Whitehead TR and Cotta MA Sequence analyses of a broad host-range plasmid containing ermT from a tylosin-resistant Lactobacillus sp. Isolated from swine feces. 2001 Curr. Microbiol. pmid:11375658
Claesson K et al. Sirolimus and erythromycin interaction: two cases. 2001 Transplant. Proc. pmid:11377477
Kim C et al. The role of serine-246 in cytochrome P450eryF-catalyzed hydroxylation of 6-deoxyerythronolide B. 2001 Biosci. Biotechnol. Biochem. pmid:11388449
Fox KK et al. Gonorrhea in the HIV era: a reversal in trends among men who have sex with men. 2001 Am J Public Health pmid:11392941
Sudden death in a traveler following halofantrine administration--Togo, 2000. 2001 MMWR Morb. Mortal. Wkly. Rep. pmid:11393488